MedPath

Evaluation of Hearing Aid Benefit

Not Applicable
Completed
Conditions
Hearing Loss, Sensorineural
Interventions
Device: New hearing aid
Registration Number
NCT05198713
Lead Sponsor
Sonova AG
Brief Summary

The present study will investigate the benefit of hearing aids for speech intelligibility (in both quiet and noisy environments) compared to the unaided condition. Participants will include adults with moderate to moderately severe hearing impairment. The participants will complete laboratory-based speech intelligibility assessments with binaural hearing aids and without hearing aids.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Moderate to moderately severe sensorineural hearing loss
  • Willingness to wear custom hearing instruments during the study.
  • Age-normal cognition
  • Ability to attend on-site study visits.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ExperimentalNew hearing aidAll participants will be fit with the study hearing aid and under go the same testing conditions.
Primary Outcome Measures
NameTimeMethod
Speech Intelligibility in Quiet.Day 1 and Day 15

Speech intelligibility for monosyllabic words presented in quiet. The words are presented at a fixed level and the percentage of words correctly repeated is calculated. A higher percentage is better. This was done in both unaided and aided conditions.

Secondary Outcome Measures
NameTimeMethod
Speech Intelligibility in Noise, Expressed as the Signal to Noise Ratio at Which Participant Can Correctly Repeat 50% of the WordsDay 1 and Day 15

Speech intelligibility on key words for sentences presented in noise. Noise is presented at a fixed level, and the words are presented at adaptive levels, below and above the noise level. A negative number is better, because it indicates the participant can correctly repeat 50% of the words when the words are below the level of noise. This was done at baseline in the unaided condition on Day 1 of the study, and in the aided condition on Day 15.

Trial Locations

Locations (1)

Phonak Audiology Research Center

🇺🇸

Aurora, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath